HIGHLIGHTS
- who: Jiaxuan Xu from the Department of Critical Care Medicine, Key Laboratory of Carcinogenesis University Cancer Hospital and Institute, Beijing, China have published the research: Efficacy and safety of rivaroxaban for the treatment of PICC-related upper extremity deep vein thrombosis in cancer patients: a retrospective study, in the Journal: (JOURNAL) of December/31,/2020
- what: The aim of this study was to assess the efficacy and safety of rivaroxaban for the treatment of PICCrelated UEDVT in cancer patients. Compared to the recurrence of 7-11.1% demonstrated in previous studies of LMWH treatment in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.